HER2-low breast cancer is immune-cold: insights into tumor-infiltrating immune cells and implications for immunotherapySara Pizzamiglio, Serena Di Cosimo, Adriana Blanda et al.|npj Breast Cancer|2025Cited by 1
Supplement from Alpha-smooth Muscle Actin Expression in the Stroma Predicts Resistance to Trastuzumab in Patients with Early-stage HER2-positive Breast CancerIoannis Vathiotis, David L. Rimm, Myrto Moutafi et al.|Unknown|2023Cited by 0
Figure S1 from Alpha-smooth Muscle Actin Expression in the Stroma Predicts Resistance to Trastuzumab in Patients with Early-stage HER2-positive Breast CancerIoannis Vathiotis, David L. Rimm, Myrto Moutafi et al.|Unknown|2023Cited by 0
Figure S4 from Alpha-smooth Muscle Actin Expression in the Stroma Predicts Resistance to Trastuzumab in Patients with Early-stage HER2-positive Breast CancerIoannis Vathiotis, David L. Rimm, Myrto Moutafi et al.|Unknown|2023Cited by 0
Figure S2 from Alpha-smooth Muscle Actin Expression in the Stroma Predicts Resistance to Trastuzumab in Patients with Early-stage HER2-positive Breast CancerIoannis Vathiotis, David L. Rimm, Myrto Moutafi et al.|Unknown|2023Cited by 0